Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers

American Journal of Cardiology

Volumn 94, Issue 5, 2004, Pages 632-636

  Jaatun, Hans Jakob ^a   Sutradhar, Santosh C ^c   Dickstein, Kenneth ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SMOKING; SURVIVAL RATE;

AGE FACTORS; AGED; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SMOKING;

EID: 4444346060     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.05.029     Document Type: Article

References (20)

1. C.E. Bartecchi, T.D. MacKenzie, and R.W. Schrier The human costs of tobacco use - first of two parts N Engl J Med 330 1994 907 912
2. J.Z. Ayanian, and P.D. Cleary Perceived risks of heart disease and cancer among cigarette smokers JAMA 281 1999 1019 1021
3. I. Njølstad, E. Arnesen, and P.G. Lund-Larsen Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction Circulation 93 1996 450 456
4. G.I. Barbash, H.D. White, M. Modan, R. Diaz, J.R. Hampton, J. Heikkila, A. Kristinsson, S. Moulopoulos, E.A. Paolasso, and T. van der Werf Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial Circulation 87 1993 53 58
5. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis In Myocardial Infarction (TIMI) trial, phase II. Circulation;85:1254-1264.
6. D. Himbert, J.M. Juliard, J.L. Golmard, L.J. Feldman, P. Aubry, H. Benamer, D. Karila-Cohen, L. Gauci, and P.G. Steg Revision of the "smokers paradox": smoking is not a good prognostic factor immediately after myocardial infarction Arch Mal Coeur Vaiss 94 2001 262 268
7. S.G. Gourlay, A.C. Rundle, and H.V. Barron Smoking and mortality following AMI: results from the National Registry of Myocardial Infarction 2 (NRMI 2) Nicotine Tobacco Res 4 2002 101 107
8. B.G. Angeja, S. Kermgard, M.S. Chen, M. McKay, S.A. Murphy, E.M. Antman, C.P. Cannon, E. Braunwald, and C.M. Gibson The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis 13 2002 133 139
9. G.K. Andrikopoulos, D.J. Richter, P.E. Dilaveris, A. Pipilis, A. Zaharoulis, J.E. Gialafos, P.K. Toutouzas, and E.T. Chimonas In hospital mortality of habitual smokers after acute myocardial infarction; the "smokers paradox" in a countrywide study Eur Heart J 22 2001 776 784
10. S. Gottlieb, V. Boyko, D. Zahger, J. Balkin, H. Hod, B. Pelled, S. Stern, and S. Behar Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey) J Am Coll Cardiol 28 1996 1506 1513
11. J.T. Rivers, H.D. White, D.B. Cross, B.F. Williams, and R.M. Norris Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking J Am Coll Cardiol 16 1990 340 348
12. C.L. Grines, E.J. Topol, W.W. O'Neill, B.S. George, D. Kereiakes, H.R. Phillips, J.D. Leimberger, L.H. Woodlief, and R.M. Califf Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction Circulation 91 1995 298 303
13. I.F. Purcell, N. Newall, and M. Farrer Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis Quart J Med 92 1999 327 333
14. G.S. Sonke, A.W. Stewart, R. Beaglehole, R. Jackson, and H.D. White Comparison of case fatality in smokers and non-smokers after acute cardiac event BMJ 315 1997 992 993
15. K. Dickstein, J. Kjekshus for the OPTIMAAL Study Group Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design Am J Cardiol 83 1999 477 481
16. K. Dickstein, J. Kjekshus for the OPTIMAAL Trial Steering Committee and Investigators Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (the OPTIMAAL trial) Am J Cardiol 87 2001 766 771
17. K. Dickstein, and J. Kjekshus Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial Lancet 360 2002 752 760
18. K.L. Lee, L.H. Woodlief, E.J. Topol, W.D. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. van de Werf, R.M. Califf for the GUSTO-1 Investigators Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction Circulation 91 1995 1659 1668
19. M.P. Hudson, C.B. Granger, E.J. Topol, K.S. Pieper, P.W. Armstrong, G.I. Barbash, A.D. Guerci, A. Vahanian, R.M. Califf, and E.M. Ohman Early reinfarction after fibrinolysis: experience from the Global Utilization of Streptokinase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries (GUSTO I) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) trials Circulation 104 2001 1229 1235
20. Mde HoyosE.A. Ruiz-Bailen, A. Reina-Toral, J.M. Torres-Ruiz, M. Alvarez-Bueno, F.J. Gomez Jimenez ARIAM Group Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: results of the ARIAM Register Chest 125 2004 831 840